Hematol Transfus Cell Ther
November 2024
Objective: To clinically and laboratory characterize patients with a positive direct antiglobulin test (DAT) treated at the Hospital das Clínicas of the Federal University of Goiás (HC-UFG).
Methods: A retrospective, descriptive, cross-sectional study was carried out collecting data from medical records of patients with a positive DAT who were treated at HC-UFG between August 2021 and August 2022.
Results: Eighty-four patients with positive polyspecific DAT results were screened in the clinical laboratory.